[Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria]

Wien Med Wochenschr. 2009;159(15-16):370-82. doi: 10.1007/s10354-009-0685-5.
[Article in German]

Abstract

Diagnosis and treatment of gastrointestinal stromal tumors (GIST) requires an interdisciplinary treatment approach. This strategy should be reflected by the content of this article. Austrian representatives of 'GIST relevant' specialties authored this publication on a consensual base. This manuscript should be regarded as a guideline for 'GIST involved' colleagues in Austria.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Austria
  • Benzamides
  • Biomarkers, Tumor / genetics
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • DNA Mutational Analysis
  • Disease-Free Survival
  • Endosonography
  • Evidence-Based Medicine
  • Follow-Up Studies
  • Gastrointestinal Stromal Tumors / diagnosis
  • Gastrointestinal Stromal Tumors / mortality
  • Gastrointestinal Stromal Tumors / pathology
  • Gastrointestinal Stromal Tumors / surgery*
  • Gastrointestinal Tract / pathology
  • Guidelines as Topic
  • Humans
  • Imatinib Mesylate
  • Mitotic Index
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Patient Care Team
  • Piperazines / therapeutic use
  • Prognosis
  • Proto-Oncogene Proteins c-kit / genetics
  • Pyrimidines / therapeutic use
  • Receptor, Platelet-Derived Growth Factor alpha / genetics

Substances

  • Antineoplastic Agents
  • Benzamides
  • Biomarkers, Tumor
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor alpha